BACKGROUND: Anxiety may be associated with psychiatric morbidity, disability, increased health care utilization, and mortality in Alzheimer's disease (AD) patients as it is in the general adult population. However, the phenomenology of anxiety symptoms in AD and its relationship to dementia progression, comorbid depression, and the presence of other problematic behaviors have not yet been examined. METHOD: Data on anxiety symptoms and their coexistence with other factors were obtained in 523 community-dwelling AD patients through interviews with their caregivers and direct physical examination. The prevalence of anxiety symptoms and their association to patient depression, other behavioral problems, gender, and age was investigated. RESULTS: Anxiety symptoms were common, occurring in 70% of subjects. Anxiety symptoms were significantly correlated with ADL impairment and other behavioral disturbances, including wandering, sexual misconduct, hallucinations, verbal threats, and physical abuse. Comorbidity of anxiety-depression was also prevalent: 54% of the sample had both anxiety and depression symptoms. ADL impairment and problem behaviors were significantly associated with comorbidity; however, the latter association was explained entirely by the presence of anxiety. CONCLUSION: Anxiety symptoms were common and significantly related to ADL and additional neuropsychiatric problems in this sample. These results indicate the need for additional research into the phenomenology of anxiety and comorbid anxiety-depression in AD and for the development and investigation of effective assessment and treatment of anxiety in AD clinical practice.
BACKGROUND:Anxiety may be associated with psychiatric morbidity, disability, increased health care utilization, and mortality in Alzheimer's disease (AD) patients as it is in the general adult population. However, the phenomenology of anxiety symptoms in AD and its relationship to dementia progression, comorbid depression, and the presence of other problematic behaviors have not yet been examined. METHOD: Data on anxiety symptoms and their coexistence with other factors were obtained in 523 community-dwelling ADpatients through interviews with their caregivers and direct physical examination. The prevalence of anxiety symptoms and their association to patientdepression, other behavioral problems, gender, and age was investigated. RESULTS:Anxiety symptoms were common, occurring in 70% of subjects. Anxiety symptoms were significantly correlated with ADL impairment and other behavioral disturbances, including wandering, sexual misconduct, hallucinations, verbal threats, and physical abuse. Comorbidity of anxiety-depression was also prevalent: 54% of the sample had both anxiety and depression symptoms. ADL impairment and problem behaviors were significantly associated with comorbidity; however, the latter association was explained entirely by the presence of anxiety. CONCLUSION:Anxiety symptoms were common and significantly related to ADL and additional neuropsychiatric problems in this sample. These results indicate the need for additional research into the phenomenology of anxiety and comorbid anxiety-depression in AD and for the development and investigation of effective assessment and treatment of anxiety in AD clinical practice.
Authors: A Lynn Snow; Cashuna Huddleston; Christina Robinson; Mark E Kunik; Amber L Bush; Nancy Wilson; Jessica Calleo; Amber Paukert; Cynthia Kraus-Schuman; Nancy J Petersen; Melinda A Stanley Journal: Aging Ment Health Date: 2012-02-28 Impact factor: 3.658
Authors: Jessica S Calleo; Mark E Kunik; Dana Reid; Cynthia Kraus-Schuman; Amber Paukert; Tziona Regev; Nancy Wilson; Nancy J Petersen; A Lynn Snow; Melinda Stanley Journal: Am J Alzheimers Dis Other Demen Date: 2011-11-07 Impact factor: 2.035
Authors: Christina M Robinson; Amber Paukert; Cynthia A Kraus-Schuman; A Lynn Snow; Mark E Kunik; Nancy L Wilson; Linda Teri; Melinda A Stanley Journal: Aging Ment Health Date: 2011-04 Impact factor: 3.658
Authors: Adrian Rubio-González; Juan Carlos Bermejo-Millo; Beatriz de Luxán-Delgado; Yaiza Potes; Zulema Pérez-Martínez; José Antonio Boga; Ignacio Vega-Naredo; Beatriz Caballero; Juan José Solano; Ana Coto-Montes Journal: Mol Neurobiol Date: 2017-10-30 Impact factor: 5.590
Authors: Mario F Mendez; Sylvia S Fong; Mark M Ashla; Elvira E Jimenez; Andrew R Carr Journal: J Neuropsychiatry Clin Neurosci Date: 2018-04-06 Impact factor: 2.198
Authors: Amber L Paukert; Cynthia Kraus-Schuman; Nancy Wilson; A Lynn Snow; Jessica Calleo; Mark E Kunik; Melinda A Stanley Journal: Behav Modif Date: 2013-02-26